Study on the role of zoledronic acid in treatment of postmenopausal osteoporosis women

Objective: We aimed to assess the role of zoledronic acid (ZOL) on the risk of fracture and bone mineral density (BMD) in women with osteoporosis. Methods: A double-blind and placebo-controlled design was taken in our study. 327 patients who received an intravenous 5-mg infusion zoledronic acid at d...

Descripción completa

Detalles Bibliográficos
Autores principales: Chao, Ma, Hua, Qin, Yingfeng, Zhou, Guang, Wan, Shufeng, Shi, Yuzhen, Dong, Wei, Wang, Haifeng, Tan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Professional Medical Publicaitons 2013
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3905367/
https://www.ncbi.nlm.nih.gov/pubmed/24550958

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3905367/
https://www.ncbi.nlm.nih.gov/pubmed/24550958

Ejemplares similares